TELA Bio (TELA) Depreciation & Amortization (CF) (2018 - 2026)

TELA Bio's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $169000.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 1.74% year-over-year to $169000.0 in Q1 2026; TTM through Mar 2026 was $597000.0, a 10.23% decrease from a year earlier, with the FY2025 full-year figure at $600000.0, down 5.06% from the prior year.
• Depreciation & Amortization (CF) improved to $169000.0 in Q1 2026 per TELA's latest filing, from $100000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $175000.0 in Q2 2025 and bottomed at $38000.0 in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $123000.0 (2023), against an average of $128470.6.
• Across the five-year window, Depreciation & Amortization (CF) slumped 66.07% in 2023 and jumped 350.0% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $112000.0 in 2022, then slumped by 66.07% to $38000.0 in 2023, then soared by 350.0% to $171000.0 in 2024, then tumbled by 41.52% to $100000.0 in 2025, then surged by 69.0% to $169000.0 in 2026.
• Per Business Quant, the three latest TELA Depreciation & Amortization (CF) figures stand at $169000.0 (Q1 2026), $100000.0 (Q4 2025), and $153000.0 (Q3 2025).